...
首页> 外文期刊>The American Journal of Tropical Medicine and Hygiene >In-Hospital Death after Septic Shock Reversal: A Retrospective Analysis of In-Hospital Death among Septic Shock Survivors at Thailand's Largest National Tertiary Referral Center
【24h】

In-Hospital Death after Septic Shock Reversal: A Retrospective Analysis of In-Hospital Death among Septic Shock Survivors at Thailand's Largest National Tertiary Referral Center

机译:渗透休克后,在医院死亡逆转:泰国最大的国家三级推荐中心的脓液休克幸存者中医院死亡的回顾性分析

获取原文
获取原文并翻译 | 示例
           

摘要

Advances in sepsis resuscitation have significantly improved shock control; however, many patients still die after septic shock reversal. We conducted a retrospective review to examine in-hospital death in whom shock was reversed and vasopressor was discontinued for 72 hours or longer. Factors independently associated with death were determined. Medical records of septic shock survivors from the medical intensive care unit of the Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, during January 2012-January 2019 were analyzed. A total of 350 septic shock patients were enrolled. Of these, 280 survived initial resuscitation. Eighty of 280 patients died, 45 died by 28 days (16.1%), and 35 (12.5%) died thereafter during their hospital stay. Multi-organ failure and hospital-acquired pneumonia (HAP) were the leading causes of death, followed by other infection and noninfectious complication. Although the death group had more laboratory derangement and required more organ support, there were four factors associated with mortality from multivariate analysis. Hospital-acquired pneumonia was the leading factor, followed by sequential organ failure assessment score and serum albumin at 72 hours after discontinuation of vasopressors, and total intravenous fluid during 72 hours after discontinuation of vasopressors. In-hospital mortality after hemodynamic restoration in patients with septic shock was substantial. Causes and contributing factors were identified. Measures to mitigate these risks would be beneficial for rendering more favorable patient outcomes.
机译:脓毒症复苏的进展显著改善了休克控制;然而,许多患者在感染性休克逆转后仍然死亡。我们进行了一项回顾性研究,以检查休克逆转、血管升压药停用72小时或更长时间的住院死亡病例。确定了与死亡独立相关的因素。分析了2012年1月至2019年1月期间,泰国曼谷马希隆大学医学院Siriraj医院内科重症监护室感染性休克幸存者的病历。共有350名感染性休克患者入选。其中280人在最初的复苏中存活。280名患者中有80人死亡,45人在28天内死亡(16.1%),35人(12.5%)在住院期间死亡。多器官衰竭和医院获得性肺炎(HAP)是死亡的主要原因,其次是其他感染和非感染性并发症。虽然死亡组有更多的实验室紊乱,需要更多的器官支持,但从多变量分析来看,有四个因素与死亡率相关。医院获得性肺炎是主要因素,其次是连续性器官衰竭评估评分和停药72小时后的血清白蛋白,以及停药72小时内的静脉输液总量。感染性休克患者血流动力学恢复后的住院死亡率相当高。确定了原因和促成因素。减轻这些风险的措施将有助于改善患者的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号